Gastroenterology · Brooklyn, NY
NPI
1720236813
Since 2008
Specialty
Gastroenterology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2315 86th St
Brooklyn, NY, 11214
Phone (718) 333-0093
Groups this clinician bills Medicare through
Medicare paid, 2024
$68K
516 services
Medicare patients, 2024
158
Average age 72
Drug cost, 2024
$1.5M
8,337 prescriptions
Company payments, 2025
$11K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Po Cheng Chu was code 99213 (office e&m - established), 188 times for 114 patients. In total Po Cheng Chu billed 516 services in 18 codes, and Medicare paid $68K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-06-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 188 | 114 | $77.12 | $14K |
| 99203 Office E&M - New | Office | 69 | 68 | $92.80 | $6,403 |
| 43239 Upper GI Endoscopy | Office | 58 | 58 | $315.77 | $18K |
| 45380 Lower GI Endoscopy - Other | Office | 43 | 43 | $338.55 | $15K |
| 99214 Office E&M - Established | Office | 22 | 21 | $100.67 | $2,215 |
By year: 2022 $100K for 564 services; 2023 $70K for 423 services; 2024 $68K for 516 services.
Medicare prescription drug claims, 2024
In 2024, the drug Po Cheng Chu prescribed most often to Medicare patients was Pantoprazole Sodium, with 2,263 prescriptions and refills. In total Po Cheng Chu wrote 8,337 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 2,263 | 2,593 | 918 | $11K |
| Famotidine Generic | 770 | 934 | 332 | $9,906 |
| Dicyclomine Hcl Generic | 611 | 624 | 374 | $4,087 |
| Sucralfate Generic | 591 | 669 | 350 | $15K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 576 | 576 | 566 | $35K |
| Nexium Esomeprazole Magnesium | 391 | 409 | 111 | $111K |
| Omeprazole Generic | 358 | 403 | 156 | $3,212 |
| Lansoprazole Generic | 302 | 351 | 134 | $2,990 |
| Creon Lipase/Protease/Amylase | 270 | 338 | 118 | $355K |
| Esomeprazole Magnesium Generic | 253 | 293 | 102 | $3,510 |
| Linzess Linaclotide | 248 | 260 | 91 | $137K |
| Procto-Med Hc Hydrocortisone | 172 | 174 | 82 | $1,462 |
| Hydrocortisone Generic | 132 | 134 | 71 | $2,192 |
| Dexlansoprazole Dr Dexlansoprazole | 112 | 130 | 44 | $19K |
| Mesalamine Generic | 98 | 109 | 36 | $21K |
Brand drugs: - claims; generic drugs: 6,691 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Po Cheng Chu $11K ($11K in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbvie Inc. with $9,855.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 29 | $9,855 |
| Janssen Biotech, Inc. JNJ | 10 | $274 |
| Madrigal Pharmaceuticals MDGL | 10 | $222 |
| Vivus LLC | 10 | $206 |
| Aimmune Therapeutics, Inc. | 9 | $200 |
| Gilead Sciences, Inc. GILD | 4 | $90.72 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $41.56 |
| Ardelyx, Inc. ARDX | 1 | $22.33 |
| Phathom Pharmaceuticals, Inc. PHAT | 1 | $19.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.